
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Daniel C. Malone, RPh, PhD, FAMCP, offers suggestions for improving drug interaction alert presentation.
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, offers suggestions for improving drug interaction alert presentation.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.






